Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution. (Q50682895)
Jump to navigation
Jump to search
scientific article published on 13 August 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution. |
scientific article published on 13 August 2007 |
Statements
1 reference
2 references
Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution. (English)
1 reference
Ehud Zigmond
1 reference
Rifaat Safadi
1 reference
Orit Pappo
1 reference
Zvi Shalev
1 reference
Yaron Ilan
1 reference
13 August 2007
1 reference
19
1 reference
8
1 reference
1021-1029
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference